Pingping Hu

1.4k total citations
65 papers, 1.1k citations indexed

About

Pingping Hu is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Pingping Hu has authored 65 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 18 papers in Molecular Biology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Pingping Hu's work include Cancer Immunotherapy and Biomarkers (13 papers), Lung Cancer Treatments and Mutations (8 papers) and Lung Cancer Research Studies (8 papers). Pingping Hu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (13 papers), Lung Cancer Treatments and Mutations (8 papers) and Lung Cancer Research Studies (8 papers). Pingping Hu collaborates with scholars based in China, United States and Germany. Pingping Hu's co-authors include Jiajun Du, Hongchang Shen, Keke Sun, Cheng Zhi Huang, Liqiang Chen, Li Zhang, Sizhou Huang, Lingfei Luo, Yuemei Xu and Guanghui Wang and has published in prestigious journals such as PLoS ONE, Scientific Reports and The Plant Journal.

In The Last Decade

Pingping Hu

62 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pingping Hu China 17 422 294 256 247 140 65 1.1k
Lijun Xue China 23 413 1.0× 691 2.4× 176 0.7× 260 1.1× 86 0.6× 51 1.3k
Tiancheng Zhao China 20 311 0.7× 471 1.6× 157 0.6× 292 1.2× 76 0.5× 52 1.1k
Yinting Chen China 22 473 1.1× 544 1.9× 156 0.6× 288 1.2× 206 1.5× 57 1.3k
Qiqing Sun China 16 357 0.8× 510 1.7× 211 0.8× 301 1.2× 61 0.4× 38 941
Kaihong Huang China 24 643 1.5× 752 2.6× 182 0.7× 411 1.7× 167 1.2× 64 1.5k
Weiwei Sheng China 23 471 1.1× 933 3.2× 196 0.8× 370 1.5× 46 0.3× 72 1.6k
Hidenori Miyake Japan 20 336 0.8× 429 1.5× 210 0.8× 148 0.6× 42 0.3× 96 1.6k
Nong Xu China 18 506 1.2× 289 1.0× 425 1.7× 117 0.5× 31 0.2× 90 1.1k
Na Song China 19 342 0.8× 705 2.4× 146 0.6× 247 1.0× 104 0.7× 78 1.6k
Xiaozheng Kang China 18 275 0.7× 318 1.1× 359 1.4× 266 1.1× 50 0.4× 68 976

Countries citing papers authored by Pingping Hu

Since Specialization
Citations

This map shows the geographic impact of Pingping Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pingping Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pingping Hu more than expected).

Fields of papers citing papers by Pingping Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pingping Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pingping Hu. The network helps show where Pingping Hu may publish in the future.

Co-authorship network of co-authors of Pingping Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Pingping Hu. A scholar is included among the top collaborators of Pingping Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pingping Hu. Pingping Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Xin, et al.. (2024). Effect of immune checkpoint inhibitors at different treatment time periods on prognosis of patients with extensive-stage small-cell lung cancer. Clinical & Translational Oncology. 26(9). 2339–2350. 1 indexed citations
2.
Liang, Ning, Yingying Zhang, Yan Zhang, et al.. (2023). Effect of Sequence of Radiotherapy Combined With Immunotherapy on the Incidence of Pneumonitis in Patients With Lung Cancer: A Systematic Review and Network Meta-Analysis. Clinical Lung Cancer. 25(1). 18–28.e3. 6 indexed citations
3.
4.
5.
Bai, Shuai, Tiantian Tian, Jose M. Pacheco, et al.. (2021). Immune-related adverse event profile of combination treatment of PD-(L)1 checkpoint inhibitors and bevacizumab in non-small cell lung cancer patients: data from the FDA adverse event reporting system. Translational Lung Cancer Research. 10(6). 2614–2624. 26 indexed citations
6.
Li, Xixi, et al.. (2020). Systemic Immune-Inflammation Index Predicted Overall Survival and Radiosensitivity in Advanced Non-Small-Cell Lung Cancer. Future Oncology. 16(5). 103–115. 12 indexed citations
7.
8.
Guo, Xiaogang, Tao Han, Pingping Hu, et al.. (2018). Five microRNAs in serum as potential biomarkers for prostate cancer risk assessment and therapeutic intervention. International Urology and Nephrology. 50(12). 2193–2200. 33 indexed citations
9.
Yu, Jie, et al.. (2017). CCR7 promote lymph node metastasis via regulating VEGF-C/D-R3 pathway in lung adenocarcinoma. Journal of Cancer. 8(11). 2060–2068. 20 indexed citations
10.
Hu, Pingping, Naixin Liang, Jian Xie, et al.. (2017). Concurrent chemoradiotherapy with weekly nedaplatin versus radiotherapy alone in elderly patients with non-small-cell lung cancer. Clinical & Translational Oncology. 20(3). 294–301. 3 indexed citations
11.
Su, Meng, Xueyang Dong, Pingping Hu, et al.. (2016). Cinnamon effectively inhibits the activity of leukemia stem cells. Genetics and Molecular Research. 15(3). 4 indexed citations
12.
Sun, Haifeng, Pingping Hu, Hongchang Shen, et al.. (2015). Albumin and Neutrophil Combined Prognostic Grade as a New Prognostic Factor in Non-Small Cell Lung Cancer: Results from a Large Consecutive Cohort. PLoS ONE. 10(12). e0144663–e0144663. 31 indexed citations
13.
Yang, Zhao, Hongchang Shen, Chen Qiu, et al.. (2015). Invasion Types Are Associated With Poor Prognosis in Lung Squamous Carcinoma Patients. Medicine. 94(43). e1634–e1634. 15 indexed citations
14.
Hu, Pingping, Hongchang Shen, Guanghui Wang, et al.. (2014). Prognostic Significance of Systemic Inflammation-Based Lymphocyte- Monocyte Ratio in Patients with Lung Cancer: Based on a Large Cohort Study. PLoS ONE. 9(10). e108062–e108062. 132 indexed citations
15.
Yang, Miaomiao, Hongxin Cao, Tiehong Zhang, et al.. (2013). The Number of Resected Lymph Nodes (nLNs) Combined with Tumor Size as a Prognostic Factor in Patients with Pathologic N0 and Nx Non-Small Cell Lung Cancer. PLoS ONE. 8(9). e73220–e73220. 24 indexed citations
16.
Hu, Pingping, et al.. (2013). Haemoptysis as a prognostic factor in lung adenocarcinoma after curative resection. British Journal of Cancer. 109(6). 1609–1617. 15 indexed citations
17.
Hu, Pingping, Weidong Liu, Liguang Wang, Miaomiao Yang, & Jiajun Du. (2013). High circulating VEGF level predicts poor overall survival in lung cancer. Journal of Cancer Research and Clinical Oncology. 139(7). 1157–1167. 24 indexed citations
18.
Hu, Pingping, et al.. (2013). High expression of CXCR-2 correlates with lymph node metastasis and predicts unfavorable prognosis in resected esophageal carcinoma. Medical Oncology. 31(2). 809–809. 30 indexed citations
19.
Hu, Pingping, Dong Fang, & Miao Chen. (2011). 1,25-(OH)2D3 enhances the chemotherapeutic effect of doxorubicin on gastric carcinoma cells. Tumori. 31(4). 304–309. 1 indexed citations
20.
Hu, Pingping. (2001). Methods of Assaying Laccase Activity by Panus Conchatus. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lijun Xue Breakdown of academic impact, for papers by Tiancheng Zhao Breakdown of academic impact, for papers by Yinting Chen Breakdown of academic impact, for papers by Qiqing Sun Breakdown of academic impact, for papers by Kaihong Huang Breakdown of academic impact, for papers by Weiwei Sheng Breakdown of academic impact, for papers by Hidenori Miyake Breakdown of academic impact, for papers by Nong Xu Breakdown of academic impact, for papers by Na Song Breakdown of academic impact, for papers by Xiaozheng Kang
Rankless by CCL
2026